1011.HK
Price:
$0.83
Market Cap:
$508.28M
China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is head...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-04-20
Stock Exchange
HKSE
Ticker
1011.HK
According to China NT Pharma Group Company Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 820.37M. This represents a change of 20.77% compared to the average of 679.30M of the last 4 quarters.
The mean historical Enterprise Value of China NT Pharma Group Company Limited over the last ten years is 68.54B. The current 820.37M Enterprise Value has changed 19.69% with respect to the historical average. Over the past ten years (40 quarters), 1011.HK's Enterprise Value was at its highest in in the December 2015 quarter at 330.90B. The Enterprise Value was at its lowest in in the January 2010 quarter at 0.
Average
68.54B
Median
14.87B
Minimum
433.30M
Maximum
298.68B
Discovering the peaks and valleys of China NT Pharma Group Company Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 301.96%
Maximum Annual Enterprise Value = 298.68B
Minimum Annual Increase = -89.82%
Minimum Annual Enterprise Value = 433.30M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 433.30M | -44.55% |
| 2023 | 781.46M | -19.56% |
| 2022 | 971.45M | -49.28% |
| 2021 | 1.92B | -30.32% |
| 2020 | 2.75B | -89.82% |
| 2019 | 27.00B | -77.06% |
| 2018 | 117.72B | 301.96% |
| 2017 | 29.29B | -85.78% |
| 2016 | 205.90B | -31.06% |
| 2015 | 298.68B | 171.30% |
The current Enterprise Value of China NT Pharma Group Company Limited (1011.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
728.73M
5-year avg
1.37B
10-year avg
68.54B
China NT Pharma Group Company Limited’s Enterprise Value is greater than Fusen Pharmaceutical Company Limited (819.14M), greater than Zhongzhi Pharmaceutical Holdings Limited (469.11M), greater than Wai Yuen Tong Medicine Holdings Limited (741.88M), greater than MOG Holdings Limited (234.95M), greater than Modern Chinese Medicine Group Co., Ltd. (109.25M), greater than Yunkang Group Limited (361.60M), greater than Vincent Medical Holdings Limited (492.38M), greater than Rainmed Medical Limited (317.87M), greater than Austar Lifesciences Limited (648.74M), greater than Tianda Pharmaceuticals Limited (271.81M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 819.14M | $584.05M | |
| 469.11M | $523.12M | |
| 741.88M | $438.79M | |
| 234.95M | $494.01M | |
| 109.25M | $432.00M | |
| 361.60M | $585.34M | |
| 492.38M | $533.91M | |
| 317.87M | $371.36M | |
| 648.74M | $502.33M | |
| 271.81M | $230.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China NT Pharma Group Company Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like China NT Pharma Group Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is China NT Pharma Group Company Limited's Enterprise Value?
What is the highest Enterprise Value for China NT Pharma Group Company Limited (1011.HK)?
What is the 3-year average Enterprise Value for China NT Pharma Group Company Limited (1011.HK)?
What is the 5-year average Enterprise Value for China NT Pharma Group Company Limited (1011.HK)?
How does the current Enterprise Value for China NT Pharma Group Company Limited (1011.HK) compare to its historical average?